FOLFOX (oxaliplatin, leucovorin, 5-fluorouracil [5FU])

COMBINATION_PRODUCT2 trials

Sponsors

Pfizer, Tongji Hospital

Conditions

Colorectal Liver Metastasis (CRLM)Colorectal Neoplasms

Phase 2

A Study Combining FOLFOX or FOLFIRI With AG-013736 or Bevacizumab (Avastin) in Patients With Metastatic Colorectal Cancer After Failure Of One First Line Regimen

CompletedNCT00615056

PfizerColorectal Neoplasms

Start: 2008-03-31End: 2012-04-30Updated: 2013-04-19

FOLFOX-HAIC as Conversion Treatment for Initially Unresectable Colorectal Liver Metastasis

RecruitingNCT06988852

Tongji HospitalColorectal Liver Metastasis (CRLM)

Start: 2023-05-01End: 2030-12-31Target: 300Updated: 2025-05-25